<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://saudenews.org/noticia/oms-amplia-acesso-hidroxiureia-infantil-doenca-falciforme</loc>
    <news:news>
      <news:publication>
        <news:name>Saúde News</news:name>
        <news:language>pt</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T12:07:09.380Z</news:publication_date>
      <news:title>OMS tenta ampliar acesso à hidroxiureia infantil para doença falciforme</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://saudenews.org/noticia/pm2-5-ozonio-e-no-sao-associados-a-cancer-em-analise-global</loc>
    <news:news>
      <news:publication>
        <news:name>Saúde News</news:name>
        <news:language>pt</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T09:13:32.987Z</news:publication_date>
      <news:title>PM2,5, ozônio e NO₂ são associados a câncer em análise global</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://saudenews.org/noticia/anvisa-determina-apreensao-de-dysport-falso-p22686-sem-origem-divulgada</loc>
    <news:news>
      <news:publication>
        <news:name>Saúde News</news:name>
        <news:language>pt</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T09:07:10.906Z</news:publication_date>
      <news:title>Anvisa determina apreensão de Dysport falso P22686 sem origem divulgada</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://saudenews.org/noticia/fda-aprova-genglycos-para-gsdia-a-partir-dos-8-anos-nos-eua</loc>
    <news:news>
      <news:publication>
        <news:name>Saúde News</news:name>
        <news:language>pt</news:language>
      </news:publication>
      <news:publication_date>2026-08-31T09:18:35.275Z</news:publication_date>
      <news:title>FDA aprova Genglycos para GSDIa a partir dos 8 anos nos EUA</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://saudenews.org/noticia/fda-aprova-tripla-terapia-de-primeira-linha-para-adenocarcinoma-gastroesofagico-</loc>
    <news:news>
      <news:publication>
        <news:name>Saúde News</news:name>
        <news:language>pt</news:language>
      </news:publication>
      <news:publication_date>2026-08-31T09:06:48.635Z</news:publication_date>
      <news:title>FDA aprova tripla terapia de primeira linha para adenocarcinoma gastroesofágico HER2+ avançado ou metastático</news:title>
    </news:news>
  </url>
</urlset>